Funder
the Hallym University Research Fund
the Ministry of Education
Subject
Cell Biology,Pathology and Forensic Medicine
Reference38 articles.
1. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer;Al-Kuraya;J. Clin. Pathol.,2007
2. Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification;Arnould;Clin. Cancer Res.,2007
3. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;Bang;Lancet,2010
4. Rectal cancer, version 2.2015;Benson 3rd;J. Compr. Canc. Netw.,2015
5. Impact of acellular mucin pools on survival in patients with complete pathological response to neoadjuvant treatment in rectal cancer;Bhatti;Int. J. Surg.,2014